Report on markers of inflammation-immunity using novel osmotic agents and pathways to improve patient access to anti-inflammatory cardiovascular-protective therapies in PD

Summary
Report on markers of inflammationimmunity using novel osmotic agents and pathways to improve patient access to antiinflammatory cardiovascularprotective therapies in PD